Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
D000305:Adrenal Cortex Hormones / Q000502:physiology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001362:Avoidance Learning / Q000502:physiology; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism / Q000502:physiology; D003024:Clozapine / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008032:Limbic System / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug; D012559:Schizophrenia / Q000378:metabolism*; D012653:Self Stimulation; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D000305:Adrenal Cortex Hormones; D002395:Catecholamines; D004791:Enzyme Inhibitors; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D003024:Clozapine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine